» Articles » PMID: 32671722

COVID-19 and Rhabdomyolysis

Overview
Publisher Springer
Specialty General Medicine
Date 2020 Jul 17
PMID 32671722
Citations 28
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rhabdomyolysis secondary to COVID-19 infection and vaccination: a review of literature.

Karimi M, Faal Hamedanchi N, Ansari K, Nahavandi R, Mazdak M, Javaherchian F Front Med (Lausanne). 2024; 11:1460676.

PMID: 39635585 PMC: 11614617. DOI: 10.3389/fmed.2024.1460676.


A Case of COVID-19-Triggered Polymyositis Leading to Rhabdomyolysis.

Reddy S, Vargas N, Varshney A, Karasik O Cureus. 2024; 16(7):e64267.

PMID: 39130882 PMC: 11315468. DOI: 10.7759/cureus.64267.


Profound Rhabdomyolysis and Viral Myositis Due to SARS-CoV-2: A Case Report.

Dye M, Lantz R Cureus. 2024; 16(5):e61172.

PMID: 38933630 PMC: 11200312. DOI: 10.7759/cureus.61172.


Multi-Organ Systems Involvement in COVID-19 is Associated With a Worse Prognosis.

Lam E, Gomez-Paz S, Gonzalez-Mosquera L, Mirabella S, Cardenas-Maldonado D, Fogel J J Acute Med. 2024; 14(2):61-73.

PMID: 38855050 PMC: 11153311. DOI: 10.6705/j.jacme.202406_14(2).0002.


Relationship Between Rhabdomyolysis and SARS-CoV-2 Disease Severity.

Samardzic T, Muradashvili T, Guirguis S, Felek S, Pan S, Tiyyagura S Cureus. 2024; 16(1):e53029.

PMID: 38410346 PMC: 10895313. DOI: 10.7759/cureus.53029.


References
1.
Inciardi R, Lupi L, Zaccone G, Italia L, Raffo M, Tomasoni D . Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(7):819-824. PMC: 7364333. DOI: 10.1001/jamacardio.2020.1096. View

2.
Puelles V, Lutgehetmann M, Lindenmeyer M, Sperhake J, Wong M, Allweiss L . Multiorgan and Renal Tropism of SARS-CoV-2. N Engl J Med. 2020; 383(6):590-592. PMC: 7240771. DOI: 10.1056/NEJMc2011400. View

3.
Lippi G, Lavie C, Sanchis-Gomar F . Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis. Prog Cardiovasc Dis. 2020; 63(3):390-391. PMC: 7127395. DOI: 10.1016/j.pcad.2020.03.001. View

4.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

5.
Lai C, Shih T, Ko W, Tang H, Hsueh P . Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMC: 7127800. DOI: 10.1016/j.ijantimicag.2020.105924. View